Evidence map›Paper›PMID 26857264›Full record

ArticleCancer research2016

Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer.

Nan Hu, Mitsutaka Kadota, Huaitian Liu, Christian C Abnet, Hua Su, Hailong Wu, Neal D Freedman, Howard H Yang, Chaoyu Wang, Chunhua Yan and 13 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 90 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Annals of medicine · 2023
    Article
  7. Cancers · 2022
    Article
  8. Article
  9. Review
  10. Genomic analyses reveal SCN7A is associated with the prognosis of esophageal squamous cell carcinoma.Esophagus : official journal of the Japan Esophageal Society · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Role of magnifying endoscopy with narrow-band imaging in the diagnosis of noninvasive gastric neoplasia.JGH open : an open access journal of gastroenterology and hepatology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 1 institution in 1 country.

Nan HuDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.
Mitsutaka KadotaCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
Huaitian LiuCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
Christian C AbnetDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.
Hua SuDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.
Hailong WuCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
Neal D FreedmanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.
Howard H YangCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
Chaoyu WangDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.
Chunhua YanCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
Lemin WangDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.
Sheryl GereCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
Amy HutchinsonDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland. Cancer Genomics Research Laboratory, Leidos, Gaithersburg, Maryland.
Guohong SongCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
Yuan WangShanxi Cancer Hospital, Taiyuan, Shanxi, PR China.
Ti DingShanxi Cancer Hospital, Taiyuan, Shanxi, PR China.
You-Lin QiaoCancer Institute, Chinese Academy of Medical Sciences, Beijing, PR China.
Jill KoshiolDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.
Sanford M DawseyDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.
Carol GiffenInformation Management Services, Inc., Silver Spring, Maryland.
Alisa M GoldsteinDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.
Philip R TaylorDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland. ptaylor@mail.nih.gov leemax@mail.nih.gov.
Maxwell P LeeCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland. ptaylor@mail.nih.gov leemax@mail.nih.gov.
Information Management Services · US

Funding

Esophageal cancer genetic projectZIACP010224 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI GOLDSTEIN, ALISA · 2012 to 2025
$7.3M
GENETICS AND EPIGENETICS OF CANCERZ01CP010154 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI LEE, MAXWELL P · 2000 to 2008
$1.6M
Intramural NIH HHS Z01 CP010154
6 · The paper itself

Abstract

Gastric cancer and esophageal cancer are the second and sixth leading causes of cancer-related death worldwide. Multiple genomic alterations underlying gastric cancer and esophageal squamous cell carcinoma (ESCC) have been identified, but the full spectrum of genomic structural variations and mutations have yet to be uncovered. Here, we report the results of whole-genome sequencing of 30 samples comprising tumor and blood from 15 patients, four of whom presented with ESCC, seven with gastric cardia adenocarcinoma (GCA), and four with gastric noncardia adenocarcinoma. Analyses revealed that an A>C mutation was common in GCA, and in addition to the preferential nucleotide sequence of A located 5 prime to the mutation as noted in previous studies, we found enrichment of T in the 5 prime base. The A>C mutations in GCA suggested that oxidation of guanine may be a potential mechanism underlying cancer mutagenesis. Furthermore, we identified genes with mutations in gastric cancer and ESCC, including well-known cancer genes, TP53, JAK3, BRCA2, FGF2, FBXW7, MSH3, PTCH, NF1, ERBB2, and CHEK2, and potentially novel cancer-associated genes, KISS1R, AMH, MNX1, WNK2, and PRKRIR Finally, we identified recurrent chromosome alterations in at least 30% of tumors in genes, including MACROD2, FHIT, and PARK2 that were often intragenic deletions. These structural alterations were validated using the The Cancer Genome Atlas dataset. Our studies provide new insights into understanding the genomic landscape, genome instability, and mutation profile underlying gastric cancer and ESCC development. Cancer Res; 76(7); 1714-23. ©2016 AACR.

Indexed as

Carcinoma, Squamous CellEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaFemaleGenetic Predisposition to DiseaseGenomicsHumansMaleStomach Neoplasms

Identifiers

PMID26857264
PMCPMC4873357
OpenAlexW2310029373

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.